Sana Biotechnology Inc (SANA)
9.01
-0.07
(-0.77%)
USD |
NASDAQ |
Apr 30, 09:34
Sana Biotechnology Free Cash Flow: -273.61M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -273.61M |
| September 30, 2023 | -288.28M |
| June 30, 2023 | -291.64M |
| March 31, 2023 | -307.13M |
| December 31, 2022 | -310.93M |
| September 30, 2022 | -345.56M |
| June 30, 2022 | -334.96M |
| Date | Value |
|---|---|
| March 31, 2022 | -309.80M |
| December 31, 2021 | -280.92M |
| September 30, 2021 | -212.44M |
| June 30, 2021 | -197.72M |
| March 31, 2021 | -183.06M |
| December 31, 2020 | -161.85M |
Free Cash Flow Range, Past 5 Years
-345.56M
Minimum
Sep 2022
-161.85M
Maximum
Dec 2020
-269.07M
Average
-288.28M
Median
Sep 2023
Free Cash Flow Benchmarks
| Rocket Pharmaceuticals Inc | -211.39M |
| Solid Biosciences Inc | -95.70M |
| Dyne Therapeutics Inc | -188.89M |
| Taysha Gene Therapies Inc | -80.39M |
| Tenaya Therapeutics Inc | -103.31M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -51.96M |
| Cash from Investing (Quarterly) | 15.31M |
| Cash from Financing (Quarterly) | 1.718M |
| Free Cash Flow Per Share (Quarterly) | -0.3345 |
| Free Cash Flow Yield | -15.54% |